Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma

NCT01677988 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Study was terminated due to low accrual.

Conditions

Adenocarcinoma of Head of Pancreas

Interventions

DRUG: Neo-adjuvant Chemotherapy
RADIATION: Chemoradiation
PROCEDURE: Surgical Resection

Sponsor

Medical University of South Carolina